The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127954641 12795464 1 I 20160927 20160929 20160929 EXP CA-JNJFOC-20160928524 JANSSEN STEFANOVIC A, WRIGHT A, TANG V, HOANG L. POSITIVE BLOOD CULTURES IN A PATIENT RECOVERING FROM FEBRILE NEUTROPENIA. JMM CASE REPORTS 2016;3 (3). 44.00 YR A M Y 0.00000 20160929 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127954641 12795464 1 SS DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE 1 Unknown U U 0 LIPOSOME INJECTION
127954641 12795464 2 PS DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE 1 Unknown U U 50718 LIPOSOME INJECTION
127954641 12795464 3 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown U 0 UNSPECIFIED
127954641 12795464 4 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown U 0 UNSPECIFIED
127954641 12795464 5 SS RITUXIMAB RITUXIMAB 1 Unknown U 0 UNSPECIFIED
127954641 12795464 6 SS RITUXIMAB RITUXIMAB 1 Unknown U 0 UNSPECIFIED
127954641 12795464 7 SS ETOPOSIDE. ETOPOSIDE 1 Unknown U 0 UNSPECIFIED
127954641 12795464 8 SS ETOPOSIDE. ETOPOSIDE 1 Unknown U 0 UNSPECIFIED
127954641 12795464 9 SS FILGRASTIM FILGRASTIM 1 Unknown U 0 UNSPECIFIED
127954641 12795464 10 SS FILGRASTIM FILGRASTIM 1 Unknown U 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127954641 12795464 1 Histiocytosis haematophagic
127954641 12795464 2 Diffuse large B-cell lymphoma
127954641 12795464 3 Histiocytosis haematophagic
127954641 12795464 4 Diffuse large B-cell lymphoma
127954641 12795464 5 Histiocytosis haematophagic
127954641 12795464 6 Diffuse large B-cell lymphoma
127954641 12795464 7 Histiocytosis haematophagic
127954641 12795464 8 Diffuse large B-cell lymphoma
127954641 12795464 9 Histiocytosis haematophagic
127954641 12795464 10 Diffuse large B-cell lymphoma

Outcome of event

Event ID CASEID OUTC COD
127954641 12795464 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127954641 12795464 Escherichia infection
127954641 12795464 Febrile neutropenia
127954641 12795464 Off label use
127954641 12795464 Pneumonia klebsiella
127954641 12795464 Product use issue
127954641 12795464 Streptococcal infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found